
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
MEDICUS PHARMA LTD. N460 CA58471K2020 BAW/UFN
© 2025 Xetra Newsboard
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Medicus Pharma expands patient enrollment for skin cancer study | ||
Mo | Medicus Pharma erweitert Patientenrekrutierung für Hautkrebs-Studie | ||
Mo | Medicus Pharma Ltd.: Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC) | The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90).The Company to Expand the Study into Additional Trial Sites in EuropePhiladelphia, Pennsylvania--(Newsfile... ► Artikel lesen | |
28.03. | Medicus Pharma Ltd. - 10-K, Annual Report | ||
20.03. | Medicus Pharma Ltd. - 8-K, Current Report |